Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes
Authors:
- 1 August 2023
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 221 (2) , 206-216
Abstract
Please see the Editorial Comment by Gia A. DeAngelis discussing this article. Chinese (audio/PDF) and Spanish (audio/PDF) translations are available for this article's Please see the Author Interview associated with this article. Background: Patients with nonmucinous rectal adenocarcinoma may develop mucinous changes after neoadjuvant chemotherapy, described as mucinous degeneration. The finding's significance in earlier studies has varied. Objective: To assess the frequency of mucinous degeneration on MRI after neoadjuvant therapy for rectal adenocarcinoma and to compare outcomes among patients with nonmucinous tumor, mucinous tumor, and mucinous degeneration on MRI. Methods: This retrospective study included 201 patients (mean age, 61.8±2.2 years; 81 women, 118 men) with rectal adenocarcinoma who underwent neoadjuvant therapy followed by total mesorectal excision from October 2011 to November 2015, and who underwent baseline and restaging rectal MRI examinations and had at least 2 years of follow-up. Two radiologists independently evaluated MRI examinations for mucin content, defined as T2 hyperintensity in the tumor or tumor bed, and resolved differences by consensus. Patients were classified into three groups based on mucin status: nonmucinous tumor (≤50% mucin on baseline and restaging examinations), mucinous tumor (>50% mucin on baseline and restaging examinations), and mucinous degeneration (≤50% mucin on baseline examination, >50% mucin on restaging examination). The three groups were compared. Results: Interreader agreement for mucin content, expressed as kappa, on baseline MRI was 0.893, and on restaging MRI was 0.890. A total of 156/201 (77.6%) patients had nonmucinous tumor, 34/201 (16.9%) mucinous tumor, and 11/201 (5.5%) mucinous degeneration. Mucin status was not significantly associated with complete pathologic response (P=.41), or local or distant recurrence (both P>.05). Death rate during follow-up was not significantly different (P=.06) between patients with nonmucinous tumor (23.1%), mucinous tumor (29.4%), and mucinous degeneration (9.1%). In adjusted Cox-regression analysis, using mucinous degeneration as reference, HR for overall survival rate for mucinous tumor group was 4.7 (95% CI, 0.6-38.3; P=.14), and for nonmucinous tumor was 8.0 (95% CI, 0.9-59.9; P=.06). On histopathologic assessment, all 11 patients with mucinous degeneration showed acellular mucin, yet 10/11 patients showed viable tumor (i.e., in tumors' nonmucinous portions). Conclusion: Mucinous degeneration on MRI is not significantly associated with pathologic complete response, recurrence, or survival. Clinical impact: Mucinous degeneration on MRI is uncommon and should not be deemed an indicator of pathologic complete response.Keywords
This publication has 24 references indexed in Scilit:
- Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer PatientsAnnals of Surgical Oncology, 2015
- Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapyClinical and Translational Oncology, 2015
- Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous CarcinomaAnnals of Surgical Oncology, 2015
- Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinomaAnnals of Oncology, 2013
- The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the diseaseWorld Journal of Surgical Oncology, 2012
- Significance of Acellular Mucin Pools in Rectal Carcinoma After Neoadjuvant ChemoradiotherapyAmerican Journal of Surgical Pathology, 2011
- Impact of Colloid Response on Survival After Preoperative Radiotherapy in Locally Advanced Rectal CarcinomaAmerican Journal of Surgical Pathology, 2005
- Prognostic significance of mucinous component in colorectal carcinomaTechniques in Coloproctology, 2004
- Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survivalLaboratory Investigation, 2004
- Incidence and Survival of Mucinous Adenocarcinoma of the Colorectum: A Population-Based Study From an Asian CountryDiseases of the Colon & Rectum, 2004